Active Preoperative Anemia Management to Reduce Erythrocyte Transfusion in Patients Undergoing Cardiac Surgery (APART): A Pilot, Feasibility Study
Phase of Trial: Phase I/II
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Ferumoxytol (Primary) ; Erythropoietin
- Indications Anaemia; Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms APART
- 07 Jun 2017 Biomarkers information updated
- 05 Feb 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 26 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.